A year ago the idea of having several vaccines ready to distribute within a year seemed insurmountable. But science prevailed and the recent development of the SARS-CoV2 vaccine was the fastest in history. Join us to learn how the vaccine’s development has opened a new innovation window that we can learn from for the future – and possibly prevent the next epidemic from becoming a pandemic.

COVID-19 Vaccine

What we’ve learned & what it means for the future.

Our webinar and panel discussion will explore recent achievements and challenges in the development, approval, allocation and distribution of the SARS-CoV-2 vaccine. Hear from industry, scientific and front-line experts on the COVID-19 response and the future of healthcare innovation. Our discussion will focus on new technologies, return-to-work and the health, societal and economic challenges ahead.

HOSTS

• Carol Malysz, Executive Director, RI Bio
• Bongsup Cho, PhD, RI-INBRE

MODERATOR

• Michael Elliott, MBBS, PhD, FRACP, Chief Scientific Officer, Immunovant

FEATURED SPEAKERS

• Michael Princiotta, PhD, Chief Scientific Officer, EpiVax Therapeutics
• Katie Porter, Business Development Manager, EpiVax, Inc.
• Kerry LaPlante, Pharm.D., FCCP, FIDSA, PHP Department Chair & Professor of Pharmacy, URI & RI DOH Vaccine Committee
• Advait Badkar, PhD, Senior Director, Pfizer